35:54
Arrowhead Pharma Pres. & CEO Dr. Christopher Anzalone On Taking RNA Interference Beyond The Liver
19:03
"The Making of an Investment Banker," With Jim Donovan
27:14
Transformers, the tech behind LLMs | Deep Learning Chapter 5
16:26
Addressing the Business Side of GLP-1 Manufacturing
35:25